Anti-Human Endoglin (hCD105) Immunotoxin—Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1

Endoglin (CD105) is an accessory component of the TGF-β receptor complex, which is expressed in a number of tissues and over-expressed in the endothelial cells of tumor neovasculature. Targeting endoglin with immunotoxins containing type 2 ribosome-inactivating proteins has proved an effective tool...

ver descrição completa

Detalhes bibliográficos
Autores: Barriuso, Begoña, Antolín, Pilar, Arias, F. Javier, Girotti, Alessandra, Jimenez López, Pilar, Córdoba Díaz, Manuel, Córdoba Díaz, Damián, Girbés Juan, Tomás
Tipo de documento: artigo
Data de publicação:2016
País:España
Recursos:Universidad Complutense de Madrid (UCM)
Repositório:Docta Complutense
Idioma:inglês
OAI Identifier:oai:docta.ucm.es:20.500.14352/23929
Acesso em linha:https://hdl.handle.net/20.500.14352/23929
Access Level:Acceso aberto
Palavra-chave:615.4
Recombinant musarmin
Endoglin
CD105
44G4
Anti-endoglin monoclonal antibody
Anti-tumor therapy
Cancer therapy
Tecnología farmaceútica
Descrição
Resumo:Endoglin (CD105) is an accessory component of the TGF-β receptor complex, which is expressed in a number of tissues and over-expressed in the endothelial cells of tumor neovasculature. Targeting endoglin with immunotoxins containing type 2 ribosome-inactivating proteins has proved an effective tool to reduce blood supply to B16 mice tumor xenografts. We prepared anti-endoglin immunotoxin (IT)— containing recombinant musarmin 1 (single chain ribosome- inactivating proteins) linked to the mouse anti-human CD105 44G4 mouse monoclonal antibody via N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP). The immunotoxin specifically killed L929 fibroblast mouse cells transfected with the short form of human endoglin with IC50 values in the range of 5 ˆ 10´10 to 10´9 M.